- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.06. | Quipt Home Medical Corp: Quipt Home Medical accused of leading suitor on | 2 | Stockwatch | ||
| 04.06. | Forager Capital Management Denies its Offer was Unsolicited and Requests that Quipt Terminate its Standstill Agreement | 156 | ACCESS Newswire | BIRMINGHAM, AL / ACCESS Newswire / June 4, 2025 / Forager Capital Management ("Forager"), one of the largest shareholders of Quipt Home Medical Corp. ("Quipt") (NASDAQ:QIPT)(TSX:QIPT), requests that... ► Artikel lesen | |
| 21.05. | Stocks in Play: Quipt Home Medical Corp. | 2 | Baystreet.ca | ||
| 21.05. | Quipt Home Medical Corp: Quipt Home receives $3.10-a-share buyout bid, but ... | 1 | Stockwatch | ||
| 21.05. | Quipt Home Medical addresses hostile takeover bid | 2 | The Market Herald Canada | ||
| 21.05. | Quipt Home Medical confirms receipt of unsolicited acquisition proposal from Forager | 2 | Seeking Alpha | ||
| QUIPT HOME MEDICAL Aktie jetzt für 0€ handeln | |||||
| 21.05. | Quipt Home Medical Corp.: Quipt Home Medical Confirms Receipt of Unsolicited Acquisition Proposal | 159 | GlobeNewswire (Europe) | CINCINNATI, May 21, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider focused on end-to-end respiratory... ► Artikel lesen | |
| 21.05. | Quipt Home Medical Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 21.05. | Quipt-Aktie +53%: NBC-Anleger sahnen binnen Stunden ab! | 324 | sharedeals.de | Schnell, schneller, Maximilian Ruth: Der Chefanalyst des exklusiven No Brainer Club (NBC) hat am Dienstag mal wieder ein Meisterstück abgeliefert. Er erkannte den wahren Wert einer News bei der Aktie... ► Artikel lesen | |
| 15.05. | Quipt Home Medical has price target cut at Leede | 5 | Cantech Letter | ||
| 14.05. | Canaccord cuts Quipt Home Medical stock rating on growth woes | 2 | Investing.com | ||
| 12.05. | Quipt Home Medical GAAP EPS of -$0.07 misses by $0.05, revenue of $57.4M misses by $4.43M | 1 | Seeking Alpha | ||
| 12.05. | Quipt Home Medical Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.05. | Quipt Home Medical Corp.: Quipt Home Medical Reports Fiscal Second Quarter 2025 Results | 170 | GlobeNewswire (Europe) | CINCINNATI, May 12, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory... ► Artikel lesen | |
| 12.05. | Quipt Home Medical Corp. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 09.05. | Quipt Home Medical Earnings Preview | 2 | Benzinga.com | ||
| 30.04. | Quipt Home Medical Corp: Quipt Home Medical to release Q2 2025 results May 12 | 1 | Stockwatch | ||
| 30.04. | Stocks in Play: Quipt Home Medical Corp. | 1 | Baystreet.ca | ||
| 30.04. | Quipt Home Medical Corp. to Announce Fiscal Second Quarter 2025 Financial Results on May 12, 2025 | 1 | GlobeNewswire (USA) | ||
| 24.03. | Quipt Home Medical Corp: Quipt Home talks 2025 priorities, AGM results | 1 | Stockwatch |
1 2 3 Weiter >>
41 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 48,300 | +0,52 % | ANALYSE-FLASH: Berenberg hebt Ziel für FMC auf 60 Euro - 'Buy' | HAMBURG (dpa-AFX Broker) - Die Privatbank Berenberg hat das Kursziel für Fresenius Medical Care (FMC) von 55 auf 60 Euro angehoben und die Einstufung auf "Buy" belassen. Analystin Victoria Lambert... ► Artikel lesen | |
| UNITEDHEALTH | 263,95 | -0,02 % | Dividendenbekanntmachungen (24.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) COMPAGNIE DE L ODET SA FR0000062234 - 4,4 EUR DOM DEVELOPMENT SA PLDMDVL00012 7 PLN 1,6374 EUR ELBIT SYSTEMS LTD IL0010811243 0... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,109 | +3,81 % | Sernova Biotherapeutics, Inc.: Sernova Appoints Jonathan Rigby as Interim Chair | LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its... ► Artikel lesen | |
| FAMICORD | 4,180 | 0,00 % | Original-Research: FamiCord AG (von Montega AG): Kaufen | Original-Research: FamiCord AG - von Montega AG 06.06.2025 / 17:08 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group. Für den Inhalt der Mitteilung... ► Artikel lesen | |
| M1 KLINIKEN | 14,920 | +4,19 % | Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH): Kaufen | Original-Research: M1 Kliniken AG - from First Berlin Equity Research GmbH
19.06.2025 / 12:46 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer... ► Artikel lesen | |
| BAXTER | 25,965 | 0,00 % | Baxter, Médica Sur Launch Circular Economy Program in Mexico | ||
| DAVITA | 119,65 | -1,16 % | Is DaVita Stock Underperforming the S&P 500? | ||
| EVOFEM BIOSCIENCES | - | - | Windtree Therapeutics: Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem's Hormone-Free, On-Demand Prescription Contraceptive Gel | Windtree rapidly advancing lower cost PHEXXI manufacturing under March 2025 sourcing agreement Contract inked with outside U.S manufacturer to cut PHEXXI manufacturing costs by over 50% by end of... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results | Revenues increased 9% in Q4 2025 compared to Q4 2024, and 12% in FY 2025 compared to FY 2024Net loss improved 27% in Q4 2025 compared to Q4 2024, and 29% in FY 2025 compared to FY 2024EBITDA loss improved... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,242 | +2,54 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| CYTOSORBENTS | 1,028 | -0,19 % | Cytosorbents Corp: CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb-ATR | PRINCETON, N.J., June 24, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| LIMES SCHLOSSKLINIKEN | 398,00 | +3,11 % | LIMES Schlosskliniken AG: Online-Präsentation für Investoren am 01.07.2025 | Die LIMES Schlosskliniken betreiben exklusive Privatkliniken, die auf die Behandlung stressbedingter Erkrankungen und psychischer Störungen wie Depressionen oder Burnout spezialisiert sind. Die Gruppe... ► Artikel lesen | |
| SENSEONICS | 0,446 | +5,64 % | Senseonics lays out hopes for next-gen CGM commercial timelines | ||
| UNIVERSAL HEALTH SERVICES | 154,00 | +0,65 % | Universal Health Services Stock: Is UHS Outperforming the Healthcare Sector? | ||
| VIROMED MEDICAL | 4,200 | -2,33 % | EQS-News: Viromed Medical AG: Kaltplasma-Technologie zeigt Potenzial zur signifikanten Reduktion von Todesfällen bei beatmeten Patienten | EQS-News: Viromed Medical AG
/ Schlagwort(e): Studie/Sonstiges
Viromed Medical AG: Kaltplasma-Technologie zeigt Potenzial zur signifikanten Reduktion von Todesfällen bei beatmeten... ► Artikel lesen |
QUIPT HOME MEDICAL CORP gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 1,850 Euro und damit -2,63 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu QUIPT HOME MEDICAL CORP finden Sie auf Wallstreet Online.